Recent Finacing
Recent Raise
Glycomine is a clinical-stage biotech developing intracellular substrate replacement therapies using bio-nanomaterial delivery to restore N‑glycosylation in PMM2‑CDG and other rare monogenic metabolic and protein‑misfolding disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
